SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-247425
Filing Date
2023-09-29
Accepted
2023-09-29 16:19:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFM14A d508095ddefm14a.htm DEFM14A 2743464
2 GRAPHIC g508095dsp003.jpg GRAPHIC 128357
3 GRAPHIC g508095dsp004.jpg GRAPHIC 105164
4 GRAPHIC g508095g01a03.jpg GRAPHIC 55381
5 GRAPHIC g508095g61h22.jpg GRAPHIC 24732
6 GRAPHIC g508095g98w58.jpg GRAPHIC 27080
  Complete submission text file 0001193125-23-247425.txt   3203617
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39219 | Film No.: 231295908
SIC: 2836 Biological Products, (No Diagnostic Substances)